Childress Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Sell |
760
-40
| -5% | -$17.8K | 0.09% | 169 |
|
|
2025
Q1 | $388K | Sell |
800
-4
| -0.5% | -$1.94K | 0.11% | 130 |
|
|
2024
Q4 | $324K | Buy |
804
+35
| +5% | +$14.1K | 0.09% | 143 |
|
|
2024
Q3 | $358K | Buy |
769
+16
| +2% | +$7.44K | 0.1% | 146 |
|
|
2024
Q2 | $353K | Sell |
753
-47
| -6% | -$22K | 0.1% | 138 |
|
|
2024
Q1 | $334K | Sell |
800
-69
| -8% | -$28.8K | 0.1% | 135 |
|
|
2023
Q4 | $354K | Buy |
869
+36
| +4% | +$14.6K | 0.11% | 120 |
|
|
2023
Q3 | $290K | Buy |
+833
| New | +$290K | 0.09% | 130 |
|
|
2023
Q1 | – | Sell |
-800
| Closed | -$231K | – | 174 |
|
|
2022
Q4 | $231K | Buy |
800
+13
| +2% | +$3.75K | 0.08% | 159 |
|
|
2022
Q3 | $233K | Hold |
787
| – | – | 0.09% | 147 |
|
|
2022
Q2 | $222K | Buy |
+787
| New | +$222K | 0.09% | 153 |
|
|
2021
Q1 | – | Sell |
-315
| Closed | -$74K | – | 934 |
|
|
2020
Q4 | $74K | Buy |
+315
| New | +$74K | 0.04% | 180 |
|